NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 62 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 25 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 199,000 | $205,000 | 0.29% |
Opaleye Management Inc. | 610,000 | $628,000 | 0.28% |
Redmile Group, LLC | 3,436,935 | $3,540,000 | 0.14% |
Kynam Capital Management, LP | 124,701 | $128,000 | 0.03% |
Baker Brothers Advisors | 3,821,740 | $3,936,000 | 0.02% |
Sio Capital Management, LLC | 38,312 | $39,000 | 0.02% |
Candriam S.C.A. | 781,577 | $805,000 | 0.01% |
Highland Private Wealth Management | 46,999 | $48,000 | 0.01% |
SIMON QUICK ADVISORS, LLC | 46,856 | $49,000 | 0.01% |
Point72 Asset Management, L.P. | 1,437,417 | $1,481,000 | 0.01% |